Multiple plastic tofu packaging containers noted being reused to store food items throughout the kitchen. Multiple empty ...
Actinogen Medical’s hopes—and stock price—have rebounded slightly from earlier this month, when the Australian biotech announced its cortisol blocker had failed to improve attention and memory in ...
OcuTerra Therapeutics’ investigational eye drops failed to improve disease severity or progression in a phase 2 diabetic retinopathy trial, prompting the Boston-based biotech to look at strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results